SGMS2 and type 2 diabetes mellitus: In the context of T2D development, Sugimoto et al. [28] suggested that enhanced plasma levels of very long chain ceramides contribute to the elevated glucose clearance observed in sphingomyelin synthase 2 knockout mice.